mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.0091 |
0.8 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.8 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
0.009 |
0.8 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0098 |
0.8 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0095 |
0.8 |